SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 57.19 |
Enterprise Value ($M) | -106.78 |
Book Value ($M) | 152.34 |
Book Value / Share | 3.12 |
Price / Book | 0.38 |
NCAV ($M) | 133.96 |
NCAV / Share | 2.74 |
Price / NCAV | 0.43 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.69 |
Return on Assets (ROA) | -0.48 |
Return on Equity (ROE) | -0.52 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 6.15 |
Current Ratio | 6.15 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 166.68 |
Assets | 185.05 |
Liabilities | 32.71 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -125.14 |
Net Income | -115.86 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -88.22 |
Cash from Investing | 47.29 |
Cash from Financing | 11.68 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | BlackRock, Inc. | 7.00 | -22.95 | |
13G/A | Alger Associates Inc | 2.70 | -67.81 | |
13G/A | Jennison Associates Llc | 5.10 | -51.41 | |
13G/A | Prudential Financial Inc | 5.70 | -50.51 | |
13G/A | Venrock Healthcare Capital Partners III, L.P. | 3.30 | -37.96 | |
13G | T. Rowe Price Investment Management, Inc. | 7.50 | ||
13G/A | Adage Capital Management, L.P. | 7.43 | ||
13G/A | Vanguard Group Inc | 5.22 | 0.00 | |
13G/A | State Street Corp | 1.80 | -65.46 | |
13G | Bain Capital Life Sciences Opportunities III, LP | 5.70 | 38.04 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
426,109 | 1,291,955 | 32.98 | |
604,340 | 1,606,810 | 37.61 | |
439,902 | 1,466,187 | 30.00 | |
151,948 | 508,105 | 29.90 | |
(click for more detail) |
Similar Companies | |
---|---|
BMEA – Biomea Fusion, Inc. | BMRN – BioMarin Pharmaceutical Inc. |
BPMC – Blueprint Medicines Corporation | CCCC – C4 Therapeutics, Inc. |
CGC – Canopy Growth Corporation |
Financial data and stock pages provided by
Fintel.io